Jane Norma Winter

  • 8065 Citations
1983 …2022

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research Interests

Hodgkin's disease, Leukemia, Lymphoma

Certifications and Licenses

Internal Medicine
Hematology
Medical Oncology

Training Experience

1978Internship, University of Chicago
1980Residency, University of Chicago Hospitals
1981Fellowship, Columbia Presbyterian Hospital in NYC
1982Fellowship, Northwestern University, McGaw Medical Center

Education/Academic qualification

MD, University of Pennsylvania

… → 1977

Research interests

  • Hematology
  • Non-Hodgkin's Lymphoma

Fingerprint Dive into the research topics where Jane Norma Winter is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 24 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants

Research Output

Autologous transplantation as consolidation for high risk aggressive T-cell non-Hodgkin lymphoma: a SWOG 9704 intergroup trial subgroup analysis

Al-Mansour, Z., Li, H., Cook, J. R., Constine, L. S., Couban, S., Stewart, D. A., Shea, T. C., Porcu, P., Winter, J. N., Kahl, B. S., Smith, S. M., Marcellus, D. C., Barton, K. P., Mills, G. M., LeBlanc, M., Rimsza, L. M., Forman, S. J., Leonard, J. P., Fisher, R. I., Friedberg, J. W. & 1 others, Stiff, P. J., Jul 3 2019, In : Leukemia and Lymphoma. 60, 8, p. 1934-1941 8 p.

Research output: Contribution to journalArticle

  • Controversies in the Approach to Initial Therapy of Hodgkin Lymphoma

    Allen, P. B. & Winter, J. N., May 1 2019, In : Current oncology reports. 21, 5, 39.

    Research output: Contribution to journalReview article

  • 2 Scopus citations

    Dose-adjusted EPOCH-R compared with R-CHOP as frontline therapy for diffuse large B-cell lymphoma: Clinical outcomes of the Phase III intergroup trial alliance/CALGB 50303

    Bartlett, N. L., Wilson, W. H., Jung, S. H., Hsi, E. D., Maurer, M. J., Pederson, L. D., Polley, M. Y. C., Pitcher, B. N., Cheson, B. D., Kahl, B. S., Friedberg, J. W., Staudt, L. M., Wagner-Johnston, N. D., Blum, K. A., Abramson, J. S., Reddy, N. M., Winter, J. N., Chang, J. E., Gopal, A. K., Chadburn, A. & 6 others, Mathew, S., Fisher, R. I., Richards, K. L., Schoder, H., Zelenetz, A. D. & Leonard, J. P., Jul 20 2019, In : Journal of Clinical Oncology. 37, 21, p. 1790-1799 10 p.

    Research output: Contribution to journalArticle

  • 18 Scopus citations

    Immune profiling and quantitative analysis decipher the clinical role of immune-checkpoint expression in the tumor immune microenvironment of DLBCL

    Xu-Monette, Z. Y., Xiao, M., Au, Q., Padmanabhan, R., Xu, B., Hoe, N., Rodríguez-Perales, S., Torres-Ruiz, R., Manyam, G. C., Visco, C., Miao, Y., Tan, X., Zhang, H., Tzankov, A., Wang, J., Dybkær, K., Tam, W., You, H., Bhagat, G., Hsi, E. D. & 13 others, Ponzoni, M., Ferreri, A. J. M., Møller, M. B., Piris, M. A., Han van Krieken, J., Winter, J. N., Westin, J. R., Pham, L. V., Jeffrey Medeiros, L., Rassidakis, G. Z., Li, Y., Freeman, G. J. & Young, K. H., Apr 2019, In : Cancer Immunology Research. 7, 4, p. 644-657 14 p.

    Research output: Contribution to journalArticle

  • 7 Scopus citations

    Immunoglobulin somatic hypermutation has clinical impact in DLBCL and potential implications for immune checkpoint blockade and neoantigen-based immunotherapies

    Xu-Monette, Z. Y., Li, J., Xia, Y., Crossley, B., Bremel, R. D., Miao, Y., Xiao, M., Snyder, T., Manyam, G. C., Tan, X., Zhang, H., Visco, C., Tzankov, A., Dybkaer, K., Bhagat, G., Tam, W., You, H., Hsi, E. D., Van Krieken, J. H., Huh, J. & 10 others, Ponzoni, M., Ferreri, A. J. M., Møller, M. B., Piris, M. A., Winter, J. N., Medeiros, J. T., Xu, B., Li, Y., Kirsch, I. & Young, K. H., Oct 22 2019, In : Journal for ImmunoTherapy of Cancer. 7, 1, 272.

    Research output: Contribution to journalArticle

    Open Access